|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
110.27(B) |
Last
Volume: |
6,919,020 |
Avg
Vol: |
8,403,954 |
52
Week Range: |
$48.64 - $76.12 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
319,019 |
515,317 |
1,014,661 |
2,126,174 |
Total Sell Value |
$23,643,548 |
$35,409,189 |
$61,747,133 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
15 |
27 |
45 |
80 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2012-02-28 |
4 |
D |
$6.36 |
$21,122 |
D/D |
(3,321) |
81,792 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
85,113 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2012-02-28 |
4 |
D |
$6.36 |
$16,899 |
D/D |
(2,657) |
58,012 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,380 |
60,669 |
|
- |
|
Spriggs Otha T. Iii |
SVP, Human Resources |
|
2012-02-28 |
4 |
D |
$6.36 |
$10,367 |
D/D |
(1,630) |
7,822 |
|
- |
|
Spriggs Otha T. Iii |
SVP, Human Resources |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,540 |
9,452 |
|
- |
|
Neumann Lawrence R |
SVP, Special Projects |
|
2012-02-28 |
4 |
D |
$6.36 |
$10,564 |
D/D |
(1,661) |
77,000 |
|
- |
|
Neumann Lawrence R |
SVP, Special Projects |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
78,661 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2012-02-28 |
4 |
D |
$6.36 |
$14,577 |
D/D |
(2,292) |
53,843 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
56,135 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2012-02-28 |
4 |
D |
$6.36 |
$28,162 |
D/D |
(4,428) |
102,525 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,967 |
106,953 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2012-02-28 |
4 |
D |
$6.36 |
$8,720 |
D/D |
(1,371) |
72,075 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
73,446 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2012-02-28 |
4 |
D |
$6.36 |
$21,122 |
D/D |
(3,321) |
128,805 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
132,126 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2012-02-28 |
4 |
D |
$6.36 |
$9,858 |
D/D |
(1,550) |
61,965 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,889 |
63,515 |
|
- |
|
Burns Brian R |
EVP - Global Quality & Reg Aff |
|
2012-02-28 |
4 |
D |
$6.36 |
$15,493 |
D/D |
(2,436) |
79,418 |
|
- |
|
Burns Brian R |
EVP - Global Quality & Reg Aff |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,682 |
81,854 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2012-02-28 |
4 |
D |
$6.36 |
$3,873 |
D/D |
(609) |
57,708 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,270 |
58,317 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2012-02-28 |
4 |
D |
$6.36 |
$7,263 |
D/D |
(1,142) |
70,590 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,492 |
71,732 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2012-02-24 |
4 |
D |
$6.25 |
$4,044 |
D/D |
(647) |
56,047 |
|
- |
|
1828 Records found
|
|
Page 20 of 74 |
|
|